Bravias Capital Group’s USA Compression Partners USAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$244K Buy
9,253
+127
+1% +$3.5K 0.14% 88
2026
Q1
$248K Buy
9,126
+131
+1% +$3.48K 0.16% 81
2025
Q4
$207K Buy
8,995
+142
+2% +$3.33K 0.13% 107
2025
Q3
$212K Buy
8,853
+137
+2% +$3.3K 0.14% 103
2025
Q2
$212K Buy
8,716
+534
+7% +$13.2K 0.16% 93
2025
Q1
$221K Sell
8,182
-1,576
-16% -$41.8K 0.18% 78
2024
Q4
$260K Buy
+9,758
New +$223K 0.21% 77

Other funds holding USAC

Bravias Capital Group's USAC Position: Q2 2026 in Review

Bravias Capital Group increased its USA Compression Partners (USAC) stake by 1.4% in Q2 2026, buying an estimated $3.5K and bringing the position to 9,253 shares worth $244K. The position accounts for 0.14% of the portfolio, ranked #88.

Bravias Capital Group first reported a position in USAC in Q4 2024 and has held it in 7 quarters since. The position peaked at $260K in Q4 2024. 130 funds tracked by Wall St. Rank hold USAC as of Q2 2026.

  • Bravias Capital Group held 9,253 shares of USA Compression Partners worth $244K as of Q2 2026.
  • Bravias Capital Group bought 127 USA Compression Partners shares in Q2 2026, an estimated $3.5K.
  • USA Compression Partners made up 0.14% of Bravias Capital Group's portfolio in Q2 2026, its #88 holding.
  • Bravias Capital Group first reported a position in USA Compression Partners in Q4 2024 and has held it in 7 quarters since.
  • Bravias Capital Group's USA Compression Partners position peaked at $260K in Q4 2024.
  • 130 funds tracked by Wall St. Rank held USA Compression Partners as of Q2 2026.

Based on Bravias Capital Group's 13F filing for Q2 2026, filed 30 Jul 2026.